Related Articles
Serum microRNA‑125a‑5p as a potential biomarker of HCV‑associated hepatocellular carcinoma
Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance
miR‑125a‑5p reverses epithelial‑mesenchymal transition and restores drug sensitivity by negatively regulating TAFAZZIN signaling in breast cancer
Circulating exosomal miR‑125a‑5p as a novel biomarker for cervical cancer
miR‑125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway